MP65-20 EPIGENETIC PRIMING WITH 5-AZACITIDINE INCREASES SENSITIVITY OF BLADDER CANCER CELLS TO CHEMOTHERAPEUTIC AGENTS
Yoshida T, Sharma A, Kates M, Sopko N, Liu X, Hahn N, McConkey D, Ahuja N, Bivalacqua T. MP65-20 EPIGENETIC PRIMING WITH 5-AZACITIDINE INCREASES SENSITIVITY OF BLADDER CANCER CELLS TO CHEMOTHERAPEUTIC AGENTS. Journal Of Urology 2017, 197: e861. DOI: 10.1016/j.juro.2017.02.2014.Peer-Reviewed Original Research